Bulldog Investors’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bulldog Investors’s Portfolio IBER.U Stock Details IBER.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$147K	–	352
2022 Q1	$147K	Hold	15,000	–	–	0.04%	208
2021 Q4	$150K	Hold	15,000	–	–	0.04%	196
2021 Q3	$150K	Hold	15,000	–	–	0.04%	183
2021 Q2	$151K	Hold	15,000	–	–	0.04%	190
2021 Q1	$148K	Buy	+15,000	New	+$150K	0.04%	171

Other funds holding IBER.U

Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Bulldog Investors's IBER.U Position: Q2 2022 in Review

Bulldog Investors sold out of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) in Q2 2022, closing a stake of 15,000 shares — an estimated $147K sold.

Bulldog Investors first reported a position in IBER.U in Q1 2021 and held it in 5 quarters. The position peaked at $151K in Q2 2021. 18 funds tracked by Wall St. Rank hold IBER.U as of Q2 2022.

Bulldog Investors reported no remaining Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position as of Q2 2022 after selling out during the quarter.
Bulldog Investors sold 15,000 Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant shares in Q2 2022, an estimated $147K.
Bulldog Investors first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q1 2021 and held it in 5 quarters.
Bulldog Investors's Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant position peaked at $151K in Q2 2021.
18 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q2 2022.

Based on Bulldog Investors's 13F filing for Q2 2022, filed 15 Aug 2022.